<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">usfd</journal-id><journal-title-group><journal-title xml:lang="ru">Ультразвуковая и функциональная диагностика</journal-title><trans-title-group xml:lang="en"><trans-title>Ultrasound &amp; Functional Diagnostics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0771</issn><issn pub-type="epub">2408-9494</issn><publisher><publisher-name>Vidar Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">usfd-428</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Ультразвуковая диагностика в акушерстве и гинекологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Obstetrics and Gynecology Ultrasound</subject></subj-group></article-categories><title-group><article-title>Возможности комплексного использования эхографии и онкомаркеров (СА125, HE4, ROMA) для дифференциальной диагностики опухолей яичников</article-title><trans-title-group xml:lang="en"><trans-title>Ultrasound and Tumor Markers (СА125, HE4, ROMA) in Ovarian Cancer Diagnosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisova</surname><given-names>E. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буланов</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulanov</surname><given-names>M. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пашов</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pashov</surname><given-names>A. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаренко</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarenko</surname><given-names>T. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наркевич</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Narkevic</surname><given-names>A. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ООО “Медико Профи”;&#13;
Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого<country>Россия</country></aff><aff xml:lang="en">LLC “Medico Profi";&#13;
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ГБУЗ ВО “Областной клинический онкологический диспансер”;&#13;
ГБОУ ВПО “Новгородский государственный университет имени Ярослава Мудрого”<country>Россия</country></aff><aff xml:lang="en">Vladimir Oncologic Outpatient Clinic;&#13;
Yaroslav-the-Wise Novgorod State University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГАОУ ВО “Балтийский федеральный университет имени Иммануила Канта”<country>Россия</country></aff><aff xml:lang="en">Immanuel Kant Baltic Federal University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого<country>Россия</country></aff><aff xml:lang="en">Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>03</day><month>04</month><year>2026</year></pub-date><volume>0</volume><issue>6</issue><fpage>36</fpage><lpage>52</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Борисова Е.А., Буланов М.Н., Пашов А.И., Макаренко Т.А., Наркевич А.Н., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Борисова Е.А., Буланов М.Н., Пашов А.И., Макаренко Т.А., Наркевич А.Н.</copyright-holder><copyright-holder xml:lang="en">Borisova E.A., Bulanov M.N., Pashov A.I., Makarenko T.A., Narkevic A.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://usfd.vidar.ru/jour/article/view/428">https://usfd.vidar.ru/jour/article/view/428</self-uri><abstract/><trans-abstract xml:lang="en"><p>72 women aged from 24 up to 76 years old with unilateral and bilateral ovarian lesions (with size more than 30 mm) were examined. B-mode and Doppler ultrasound data was assessed according to the score system. Cut-off value for ovarian cancer diagnosis was equal to score 8. CA125, HE4, and ROMA (Risk of Ovarian Malignancy Algorithm) were assessed before the surgery. Malignant lesions were revealed in 23 (33.3%) patients, benign - in 48 (66.4%). The only ultrasound value was higher (sensitivity - 89%, specificity - 89%, accuracy - 89%) then other diagnostic modalities in postmenopausal patients. Ultrasound was sufficient for malignant lesion diagnosis in postmenopausal period. Ultrasound and ROMA at the first step and only HE4 assessment at the second step were recommended in premenopausal patients. It increased sensitivity and specificity up to 100% in our study. Positive result of ultrasound was sufficient for malignant lesions diagnosis without considering the ROMA results. HE4 tumor marker was assessed at second step if ultrasound result was negative and ROMA result positive. Positive result of HE4 was used as the marker of malignant lesion. Lesion was considered as a benign in cases of negative HE4. Malignant lesions were excluded if ultrasound and ROMA results were negative. This algorithm should be studied more precisely. More data is needed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ультразвуковая диагностика</kwd><kwd>допплерография</kwd><kwd>опухоли яичников</kwd><kwd>рак яичников</kwd><kwd>онкомаркеры</kwd><kwd>CA125</kwd><kwd>HE4</kwd><kwd>ROMA</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ultrasound diagnostics</kwd><kwd>Doppler ultrasound</kwd><kwd>ovarian tumors</kwd><kwd>ovarian cancer</kwd><kwd>tumor markers</kwd><kwd>CA125</kwd><kwd>HE4</kwd><kwd>Risk of Ovarian Malignancy Algorithm (ROMA)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Борисова Е.А., Пашов А.И., Буланов М.Н. Современное состояние проблемы дифференциальной диагностики опухолей яичников // Сибирское медицинское обозрение. 2014. № 6. С. 14-19.</mixed-citation><mixed-citation xml:lang="en">Борисова Е.А., Пашов А.И., Буланов М.Н. Современное состояние проблемы дифференциальной диагностики опухолей яичников // Сибирское медицинское обозрение. 2014. № 6. С. 14-19.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Жорданиа К.И., Хохлова С.В. Ранний рак яичников. Наш взгляд на проблему // Онкогинекология. 2012. № 1. С. 51-58.</mixed-citation><mixed-citation xml:lang="en">Жорданиа К.И., Хохлова С.В. Ранний рак яичников. Наш взгляд на проблему // Онкогинекология. 2012. № 1. С. 51-58.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Никогосян С.О., Кузнецов В.В. Современная диагностика рака яичников // Российский онкологический журнал. 2013. № 5. С. 52-55.</mixed-citation><mixed-citation xml:lang="en">Никогосян С.О., Кузнецов В.В. Современная диагностика рака яичников // Российский онкологический журнал. 2013. № 5. С. 52-55.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics // CA Cancer J. Clin. 2011. V. 61. No. 2. P. 69-90.</mixed-citation><mixed-citation xml:lang="en">Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics // CA Cancer J. Clin. 2011. V. 61. No. 2. P. 69-90.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Сведения о больных со злокачественными новообразованиями за 2012 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2012. 9 с.</mixed-citation><mixed-citation xml:lang="en">Сведения о больных со злокачественными новообразованиями за 2012 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2012. 9 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сведения о больных со злокачественными новообразованиями за 2013 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2013. 9 с.</mixed-citation><mixed-citation xml:lang="en">Сведения о больных со злокачественными новообразованиями за 2013 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2013. 9 с.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сведения о больных со злокачественными новообразованиями за 2014 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2014. 9 с.</mixed-citation><mixed-citation xml:lang="en">Сведения о больных со злокачественными новообразованиями за 2014 год: Федеральное государственное статистическое наблюдение / Министерство здравоохранения Красноярского края. Красноярск, 2014. 9 с.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Лихтенштейн А.В., Жорданиа К.И. Раковые клетки: функциональная иерархия и взаимопревращения // Онкогинекология. 2013. № 3. С. 15-19.</mixed-citation><mixed-citation xml:lang="en">Лихтенштейн А.В., Жорданиа К.И. Раковые клетки: функциональная иерархия и взаимопревращения // Онкогинекология. 2013. № 3. С. 15-19.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Прокопенко С.А., Борисенко С.А., Полторанина В.С., Шелепова В.М., Терентьев А.А. Опухоли яичников: особенности эволюции, распространения, диагностики и профилактики // Гинекология. 2011. № 1. С. 63-69.</mixed-citation><mixed-citation xml:lang="en">Прокопенко С.А., Борисенко С.А., Полторанина В.С., Шелепова В.М., Терентьев А.А. Опухоли яичников: особенности эволюции, распространения, диагностики и профилактики // Гинекология. 2011. № 1. С. 63-69.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Буланов М.Н. Значение трансвагинальной цветовой допплерографии в сочетании с импульсной допплерометрией для дифференциальной диагностики доброкачественных и злокачественных новообразований яичников: дис. … канд. мед. наук. М., 1999. 165 с.</mixed-citation><mixed-citation xml:lang="en">Буланов М.Н. Значение трансвагинальной цветовой допплерографии в сочетании с импульсной допплерометрией для дифференциальной диагностики доброкачественных и злокачественных новообразований яичников: дис. … канд. мед. наук. М., 1999. 165 с.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Van Gorp T., Veldman J., Van Calster B., Cadron I., Leunen K., Amant F., Timmerman D., Vergote I. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses // Eur. J. Cancer. 2012. V. 48. No. 11. P. 1649-1656.</mixed-citation><mixed-citation xml:lang="en">Van Gorp T., Veldman J., Van Calster B., Cadron I., Leunen K., Amant F., Timmerman D., Vergote I. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses // Eur. J. Cancer. 2012. V. 48. No. 11. P. 1649-1656.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Серов В.Н., Кудрявцева Л.И. Доброкачественные опухоли и опухолевидные образования яичников. М.: Триада-Х, 1999. 149 с.</mixed-citation><mixed-citation xml:lang="en">Серов В.Н., Кудрявцева Л.И. Доброкачественные опухоли и опухолевидные образования яичников. М.: Триада-Х, 1999. 149 с.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Guo B., Bi R. Ovarian cancer: biomarker proteomic diagnosis in progress // Appl. Biochem. Biotechnol. 2012. V. 168. No. 4. Р. 910-916.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Guo B., Bi R. Ovarian cancer: biomarker proteomic diagnosis in progress // Appl. Biochem. Biotechnol. 2012. V. 168. No. 4. Р. 910-916.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ашрафян Л.А., Антонова И.Б., Ивашина С.В., Люстик А.В., Ульянова А.В., Вашакмадзе С.Л. Ранняя диагностика рака эндометрия и яичников // Практическая онкология. 2009. Т. 10. № 2 (38). С. 71-75.</mixed-citation><mixed-citation xml:lang="en">Ашрафян Л.А., Антонова И.Б., Ивашина С.В., Люстик А.В., Ульянова А.В., Вашакмадзе С.Л. Ранняя диагностика рака эндометрия и яичников // Практическая онкология. 2009. Т. 10. № 2 (38). С. 71-75.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Molina R., Escudero J.M., Auge J.M., Filella X., Foj L., Torne A., Lejarcegui J., Pahisa J. HE4 a novel tumour marker for ovarian cancer: comparison with CA125 and ROMA algorithm in patients with gynaecological diseases // Tumour Biol. 2011. V. 32. No. 6. P. 1087-1095.</mixed-citation><mixed-citation xml:lang="en">Molina R., Escudero J.M., Auge J.M., Filella X., Foj L., Torne A., Lejarcegui J., Pahisa J. HE4 a novel tumour marker for ovarian cancer: comparison with CA125 and ROMA algorithm in patients with gynaecological diseases // Tumour Biol. 2011. V. 32. No. 6. P. 1087-1095.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева Н.С., Маршутина Н.В. Опухолеассоциированные маркеры в скрининговых программах, направленных на активное выявление рака яичников: реальность, проблемы и перспективы // Практическая онкология. 2010. Т. 11. № 2. С. 110-119.</mixed-citation><mixed-citation xml:lang="en">Сергеева Н.С., Маршутина Н.В. Опухолеассоциированные маркеры в скрининговых программах, направленных на активное выявление рака яичников: реальность, проблемы и перспективы // Практическая онкология. 2010. Т. 11. № 2. С. 110-119.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jacob F., Meier M., Caduff R., Goldstein D., Pochechueva T., Hacker N., Fink D., Heinzelmann-Schwarz V. No benefit from combining HE4 and CA 125 as ovarian tumor markers in a clinical setting // Gynecol. Oncol. 2011. V. 121. No. 3. P. 487-491.</mixed-citation><mixed-citation xml:lang="en">Jacob F., Meier M., Caduff R., Goldstein D., Pochechueva T., Hacker N., Fink D., Heinzelmann-Schwarz V. No benefit from combining HE4 and CA 125 as ovarian tumor markers in a clinical setting // Gynecol. Oncol. 2011. V. 121. No. 3. P. 487-491.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Moore R.G., McMeekin D.S., Brown A.K., DiSilvestro P., Miller M.C., Allard W.J., Gajewski W., Kurman R., Bast R.C. Jr., Skates S.J. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass // Gynecol. Oncol. 2009. V. 112. No. 1. P. 40-46.</mixed-citation><mixed-citation xml:lang="en">Moore R.G., McMeekin D.S., Brown A.K., DiSilvestro P., Miller M.C., Allard W.J., Gajewski W., Kurman R., Bast R.C. Jr., Skates S.J. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass // Gynecol. Oncol. 2009. V. 112. No. 1. P. 40-46.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Van Gorp T., Cadron I., Despierre E., Daemen A., Leunen K., Amant F., Timmerman D., De Moor B., Vergote I. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of Risk of Ovarian Malignancy Algorithm // Br. J. Cancer. 2011. V. 104. No. 5. P. 863-870.</mixed-citation><mixed-citation xml:lang="en">Van Gorp T., Cadron I., Despierre E., Daemen A., Leunen K., Amant F., Timmerman D., De Moor B., Vergote I. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of Risk of Ovarian Malignancy Algorithm // Br. J. Cancer. 2011. V. 104. No. 5. P. 863-870.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Буланов М.Н. Злокачественные опухоли яичников (часть первая) // Ультразвуковая и функциональная диагностика. 2014. № 3. С. 55-78.</mixed-citation><mixed-citation xml:lang="en">Буланов М.Н. Злокачественные опухоли яичников (часть первая) // Ультразвуковая и функциональная диагностика. 2014. № 3. С. 55-78.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Буланов М.Н. Злокачественные опухоли яичников (часть вторая) // Ультразвуковая и функциональная диагностика. 2014. № 4. С. 66-92.</mixed-citation><mixed-citation xml:lang="en">Буланов М.Н. Злокачественные опухоли яичников (часть вторая) // Ультразвуковая и функциональная диагностика. 2014. № 4. С. 66-92.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Буланов М.Н. Ультразвуковая гинекология. Ч. 2. М.: Видар, 2014. 520 с.</mixed-citation><mixed-citation xml:lang="en">Буланов М.Н. Ультразвуковая гинекология. Ч. 2. М.: Видар, 2014. 520 с.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Никогосян С.О., Кадакидзе З.Г., Шелепова В.М., Кузнецов В.В. Современные методы иммунодиагностики злокачественных новообразований яичников // Онкогинекология. 2014. № 3. С. 49-54.</mixed-citation><mixed-citation xml:lang="en">Никогосян С.О., Кадакидзе З.Г., Шелепова В.М., Кузнецов В.В. Современные методы иммунодиагностики злокачественных новообразований яичников // Онкогинекология. 2014. № 3. С. 49-54.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kaijser J., Bourne T., Valentin L., Sayasneh A., Van Holsbeke C., Vergote I., Testa A., Franchi C., Van Calster B., Timmerman D. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies // Ultrasound Obstet. Gynecol. 2013. V. 41. No. 1. P. 9-20.</mixed-citation><mixed-citation xml:lang="en">Kaijser J., Bourne T., Valentin L., Sayasneh A., Van Holsbeke C., Vergote I., Testa A., Franchi C., Van Calster B., Timmerman D. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies // Ultrasound Obstet. Gynecol. 2013. V. 41. No. 1. P. 9-20.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Franchi D., Sandri M., Boveri S., Ronzoni S., Aletti G., Radice D., Sideri M. Ultrasound imaging compared to a multivariate predictive algorithm combining HE4 and CA125 (ROMA) in the preoperative assessment of adnexal masses: preliminary results // Ultrasound Obstet. Gynecol. 2010. V. 36. Suppl. 1. P. 52-167.</mixed-citation><mixed-citation xml:lang="en">Franchi D., Sandri M., Boveri S., Ronzoni S., Aletti G., Radice D., Sideri M. Ultrasound imaging compared to a multivariate predictive algorithm combining HE4 and CA125 (ROMA) in the preoperative assessment of adnexal masses: preliminary results // Ultrasound Obstet. Gynecol. 2010. V. 36. Suppl. 1. P. 52-167.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kim Y.M., Whang D.H., Park J., Kim S.H., Lee S.W., Park H.A., Ha M., Choi K.H. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population // Clin. Chem. Med. 2011. V. 49. No. 3. P. 527-534.</mixed-citation><mixed-citation xml:lang="en">Kim Y.M., Whang D.H., Park J., Kim S.H., Lee S.W., Park H.A., Ha M., Choi K.H. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population // Clin. Chem. Med. 2011. V. 49. No. 3. P. 527-534.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bignotti E., Ragnoli M., Zanotti L., Calza S., Falchetti M., Lonardi S., Bergamelli S., Bandiera E., Tassi R.A., Romani C., Todeschini P., Odicino F.E., Facchetti F., Pecorelli S., Ravaggi A. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients // Br. J. Cancer. 2011. V. 104. No. 9. P. 1418-1425.</mixed-citation><mixed-citation xml:lang="en">Bignotti E., Ragnoli M., Zanotti L., Calza S., Falchetti M., Lonardi S., Bergamelli S., Bandiera E., Tassi R.A., Romani C., Todeschini P., Odicino F.E., Facchetti F., Pecorelli S., Ravaggi A. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients // Br. J. Cancer. 2011. V. 104. No. 9. P. 1418-1425.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Qiao C., Li L., Zhao X., Li Y. Serum HE4 is more suitable as a biomarker then CA125 in Chinese women with benign gynecologic disorders // Afr. Health Sci. 2014. V. 14. No. 4. P. 913-918.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Qiao C., Li L., Zhao X., Li Y. Serum HE4 is more suitable as a biomarker then CA125 in Chinese women with benign gynecologic disorders // Afr. Health Sci. 2014. V. 14. No. 4. P. 913-918.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ros C., Martinez-Serrano M., Rius M., Moilna R., Fuste P. Role of HE4, CA125, ROMA and ultrasound findings for adnexal mass differential diagnosis // Ultrasound Obstet. Gynecol. 2014. V. 44. Suppl. 1. P. 6.</mixed-citation><mixed-citation xml:lang="en">Ros C., Martinez-Serrano M., Rius M., Moilna R., Fuste P. Role of HE4, CA125, ROMA and ultrasound findings for adnexal mass differential diagnosis // Ultrasound Obstet. Gynecol. 2014. V. 44. Suppl. 1. P. 6.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kaijser J., Van Gorp T., Smet M.E., Van Holsbeke C., Sayasneh A., Epstein E., Bourne T., Vergote I., Van Calster B., Timmerman D. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography? // Ultrasound Obstet. Gynecol. 2014. V. 43. No. 1. P. 89-97.</mixed-citation><mixed-citation xml:lang="en">Kaijser J., Van Gorp T., Smet M.E., Van Holsbeke C., Sayasneh A., Epstein E., Bourne T., Vergote I., Van Calster B., Timmerman D. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography? // Ultrasound Obstet. Gynecol. 2014. V. 43. No. 1. P. 89-97.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Valentin L., Ameye L., Franchi D., Guerriero S., Jurkovic D., Savelli L., Fischerova D., Lissoni A., Van Holsbeke C., Fruscio R., Van Huffel S., Testa A., Timmerman D. Risk of malignancy in unilocular cysts: a study of 1 148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature // Ultrasound Obstet. Gynecol. 2013. V. 41. No. 1. P. 80-89.</mixed-citation><mixed-citation xml:lang="en">Valentin L., Ameye L., Franchi D., Guerriero S., Jurkovic D., Savelli L., Fischerova D., Lissoni A., Van Holsbeke C., Fruscio R., Van Huffel S., Testa A., Timmerman D. Risk of malignancy in unilocular cysts: a study of 1 148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature // Ultrasound Obstet. Gynecol. 2013. V. 41. No. 1. P. 80-89.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
